Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eccles

Showing results (231-240 of 340) with videos related to

Pageof 34
Sort By:
Journal of Clinical Pathology|March 27, 2012
Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort studyEmily Clare Shaw, Andrew M Hanby, Kevin Wheeler, et al.
NPJ Genomic Medicine|February 27, 2018
Clinical testing of <i>BRCA1</i> and <i>BRCA2</i>: a worldwide snapshot of technological practicesAmanda Ewart Toland, Andrea Forman, Fergus J Couch, et al.
Human Mutation|June 1, 2010
Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicityLogan C Walker, Phillip J Whiley, Fergus J Couch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2023
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and SurvivalJosephine M N Lopes Cardozo, Irene L Andrulis, Stig E Bojesen, et al.
The Lancet. Oncology|May 10, 2025
Long-term health outcomes of bilateral salpingo-oophorectomy in BRCA1 and BRCA2 pathogenic variant carriers with personal history of breast cancer: a retrospective cohort study using linked electronic health recordsHend Hassan, Isaac Allen, Tameera Rahman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening StudyAdam N Rosenthal, Lindsay S M Fraser, Susan Philpott, et al.
Journal of Medical Genetics|March 24, 2021
High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancerD Gareth Evans, Elke Maria van Veen, Helen J Byers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2022
Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK)Lucy Loong, Alice Garrett, Sophie Allen, et al.
Journal of Medical Genetics|April 10, 2019
Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA reportAmanda B Spurdle, Stephanie Greville-Heygate, Antonis C Antoniou, et al.
Journal of Medical Genetics|October 21, 2024
Lynch syndrome diagnostic testing pathways in endometrial cancers: a nationwide English registry-based studyLucy Loong, Catherine Huntley, Joanna Pethick, et al.
Pageof 34

Showing results (231-240 of 340) with videos related to

Sort By:
Pageof 34
Journal of Clinical Pathology|March 27, 2012
Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort studyEmily Clare Shaw, Andrew M Hanby, Kevin Wheeler, et al.
NPJ Genomic Medicine|February 27, 2018
Clinical testing of <i>BRCA1</i> and <i>BRCA2</i>: a worldwide snapshot of technological practicesAmanda Ewart Toland, Andrea Forman, Fergus J Couch, et al.
Human Mutation|June 1, 2010
Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicityLogan C Walker, Phillip J Whiley, Fergus J Couch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2023
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and SurvivalJosephine M N Lopes Cardozo, Irene L Andrulis, Stig E Bojesen, et al.
The Lancet. Oncology|May 10, 2025
Long-term health outcomes of bilateral salpingo-oophorectomy in BRCA1 and BRCA2 pathogenic variant carriers with personal history of breast cancer: a retrospective cohort study using linked electronic health recordsHend Hassan, Isaac Allen, Tameera Rahman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening StudyAdam N Rosenthal, Lindsay S M Fraser, Susan Philpott, et al.
Journal of Medical Genetics|March 24, 2021
High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancerD Gareth Evans, Elke Maria van Veen, Helen J Byers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2022
Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK)Lucy Loong, Alice Garrett, Sophie Allen, et al.
Journal of Medical Genetics|April 10, 2019
Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA reportAmanda B Spurdle, Stephanie Greville-Heygate, Antonis C Antoniou, et al.
Journal of Medical Genetics|October 21, 2024
Lynch syndrome diagnostic testing pathways in endometrial cancers: a nationwide English registry-based studyLucy Loong, Catherine Huntley, Joanna Pethick, et al.
Pageof 34